v3.25.4
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities    
Net loss $ (8,079) $ (9,340)
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest accretion on escrow receivable (11) 0
Accretion on investments 0 (37)
Write-downs of inventory 0 798
Depreciation and amortization 172 205
Stock-based compensation 217 441
Non-cash lease expense 342 321
Increase (decrease) in cash resulting from changes in:    
Accounts receivable (3) 7
Inventory 0 (501)
Prepaid expenses and other assets 519 205
Accounts payable (973) 303
Accrued expenses (408) 506
Operating lease liabiliy (365) (334)
Net cash used in operating activities (8,589) (7,426)
Cash Flows from Investing Activities    
Purchases of fixed assets 0 (13)
Purchases of investments 0 (2,463)
Maturities of investments 0 2,500
Net cash provided by investing activities 0 24
Cash Flows from Financing Activities    
Proceeds from issuance of common stock, net 1,811 5,662
Repayment of insurance premium financing liability (246) 0
Net cash provided by financing activities 1,565 5,662
Net decrease in cash, cash equivalents, and restricted cash (7,024) (1,740)
Cash, cash equivalents, and restricted cash at beginning of period 11,455 3,044
Cash, cash equivalents, and restricted cash at end of period 4,431 1,304
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 4,288 1,161
Restricted cash 143 143
Cash, cash equivalents, and restricted cash at end of period 4,431 1,304
Supplemental Disclosure of Cash Flow Information:    
Income taxes paid 2 2
Financed insurance premium exchanged for prepaid insurance 352 385
Liability to be settled in equity 0 218
Interest paid $ 8 $ 5